Mirae Asset Global ETFs Holdings’s Dyne Therapeutics DYN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DYN Stock Details DYN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Buy	75,469 +4,278	+6%	+$73.8K	﹤0.01%	1369
2025 Q4	$1.39M	Buy	71,191 +9,556	+16%	+$181K	﹤0.01%	1345
2025 Q3	$777K	Buy	61,635 +4,825	+8%	+$55K	﹤0.01%	1639
2025 Q2	$541K	Buy	56,810 +344	+0.6%	+$3.79K	﹤0.01%	1784
2025 Q1	$597K	Buy	56,466 +2,886	+5%	+$41.3K	﹤0.01%	1769
2024 Q4	$1.26M	Buy	53,580 +2,903	+6%	+$85.9K	﹤0.01%	1421
2024 Q3	$1.81M	Buy	50,677 +11,037	+28%	+$439K	﹤0.01%	1192
2024 Q2	$1.4M	Buy	+39,640	New	+$1.15M	﹤0.01%	1265

Other funds holding DYN

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's DYN Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Dyne Therapeutics (DYN) stake by 6% in Q1 2026, buying an estimated $73.8K and bringing the position to 75,469 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #1369.

Mirae Asset Global ETFs Holdings first reported a position in DYN in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.81M in Q3 2024. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

Mirae Asset Global ETFs Holdings held 75,469 shares of Dyne Therapeutics worth $1.35M as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 4,278 Dyne Therapeutics shares in Q1 2026, an estimated $73.8K.
Dyne Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1369 holding.
Mirae Asset Global ETFs Holdings first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Dyne Therapeutics position peaked at $1.81M in Q3 2024.
227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.